State Street SPDR S&P Biotech ETF
123 hedge funds and large institutions have $1.05B invested in State Street SPDR S&P Biotech ETF in 2013 Q2 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
364.4% more ownership
Funds ownership: 0% → 364.4% (+364%)
38% less call options, than puts
Call options by funds: $28.1M | Put options by funds: $45.5M
Top Buyers
Top Sellers
XBI Hedge Fund Activity: Q2 2013 in Review
123 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in State Street SPDR S&P Biotech ETF (XBI) for Q2 2013, worth a combined $1.05B.
Buyers outnumbered sellers: 123 funds opened new XBI positions and 0 closed out — a net gain of 123 holders — while 0 added to existing stakes and 0 trimmed.
- 123 institutional investors held State Street SPDR S&P Biotech ETF (XBI) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.05B of State Street SPDR S&P Biotech ETF stock for Q2 2013.
- 123 funds opened new State Street SPDR S&P Biotech ETF positions in Q2 2013 and 0 closed out, a net change of +123 holders.
Based on aggregated 13F filings for Q2 2013.